ClouDr Group (HKSE:09955) Beneish M-Score: -5.94 (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09955 ClouDr Group Ltd HKSE:09955
43 GF Score
Price HK$0.51
GF Value HK$0.81
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is ClouDr Group Beneish M-Score?

ClouDr Group HKSE:09955 +3.03% 43 Beneish M-Score is -5.94 as of Aug. 27, 2026. GuruFocus rates HKSE:09955 with a GF Score™ of 43/100 and a GF Value™ of HK$0.81 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 116 Medical Distribution companies, ClouDr Group ranks better than 97.41% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -5.94 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for ClouDr Group's Beneish M-Score or its related term are showing as below:

HKSE:09955' s Beneish M-Score Range Over the Past 10 Years
Min: -8.32   Med: -3.37   Max: -2.65
Current: -5.94

During the past 7 years, the highest Beneish M-Score of ClouDr Group was -2.65. The lowest was -8.32. And the median was -3.37.

ClouDr Group Beneish M-Score Historical Data

* Premium members only.

The historical data trend for ClouDr Group's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ClouDr Group Beneish M-Score Chart

ClouDr Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -8.32 -2.88 -2.65 -3.37 -5.94

ClouDr Group Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.65 0.00 -3.37 0.00 -5.94

HKSE:09955 vs MCK, COR, CAH: Beneish M-Score Comparison

For the Medical Distribution subindustry, ClouDr Group's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ClouDr Group Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, ClouDr Group's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where ClouDr Group's Beneish M-Score falls into.


HKSE:09955
43GF Score
ClouDr Group Ltd HKSE:09955
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ClouDr Group Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of ClouDr Group for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.052+0.528 * 0.5173+0.404 * 1.7384+0.892 * 0.4815+0.115 * 0.9449
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 2.0978+4.679 * -0.588473-0.327 * 1.4279
=-5.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was HK$417 Mil.
Revenue was HK$1,793 Mil.
Gross Profit was HK$856 Mil.
Total Current Assets was HK$1,301 Mil.
Total Assets was HK$1,860 Mil.
Property, Plant and Equipment(Net PPE) was HK$100 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$78 Mil.
Selling, General, & Admin. Expense(SGA) was HK$1,124 Mil.
Total Current Liabilities was HK$1,265 Mil.
Long-Term Debt & Capital Lease Obligation was HK$20 Mil.
Net Income was HK$-1,021 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$74 Mil.
 Total Receivables was HK$823 Mil.
Revenue was HK$3,724 Mil.
Gross Profit was HK$920 Mil.
Total Current Assets was HK$2,452 Mil.
Total Assets was HK$3,037 Mil.
Property, Plant and Equipment(Net PPE) was HK$153 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$108 Mil.
Selling, General, & Admin. Expense(SGA) was HK$1,113 Mil.
Total Current Liabilities was HK$1,445 Mil.
Long-Term Debt & Capital Lease Obligation was HK$24 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(416.933 / 1793.164) / (823.111 / 3724.141)
=0.232512 / 0.22102
=1.052

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(919.983 / 3724.141) / (856.25 / 1793.164)
=0.247032 / 0.477508
=0.5173

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1300.518 + 100.096) / 1860.363) / (1 - (2452.057 + 152.939) / 3036.675)
=0.247129 / 0.142155
=1.7384

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1793.164 / 3724.141
=0.4815

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(108.411 / (108.411 + 152.939)) / (78.322 / (78.322 + 100.096))
=0.414812 / 0.43898
=0.9449

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1124.345 / 1793.164) / (1113.093 / 3724.141)
=0.627017 / 0.298886
=2.0978

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((20.272 + 1264.619) / 1860.363) / ((24.058 + 1444.805) / 3036.675)
=0.690667 / 0.483708
=1.4279

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-1020.933 - 0 - 73.841) / 1860.363
=-0.588473

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

ClouDr Group has a M-score of -5.94 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -5.94 mean?
ClouDr Group (HKSE:09955) has a Beneish M-Score of -5.94 as of Aug. 27, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on ClouDr Group and its competitors. According to the industry distribution chart, ClouDr Group ranks #3 out of 116 companies in the Medical Distribution industry, placing it in the top 2.6%.
Is ClouDr Group's Beneish M-Score too high?
ClouDr Group's current Beneish M-Score is -5.94. Based on the distribution chart, ClouDr Group ranks #3 out of 116 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, ClouDr Group has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ClouDr Group's Beneish M-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ClouDr Group ranks #3 out of 116 companies for Beneish M-Score. This places ClouDr Group in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on ClouDr Group and its competitors. ClouDr Group's current Beneish M-Score is -5.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ClouDr Group stock overvalued right now?
Based on GuruFocus' analysis, ClouDr Group (HKSE:09955) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.81, compared to a current price of HK$0.51 — trading 37% below its estimated fair value. The current Beneish M-Score is -5.94. ClouDr Group's overall GF Score™ is 43/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For ClouDr Group (HKSE:09955), the current Beneish M-Score is -5.94 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ClouDr Group (HKSE:09955) Overvalued in 2026?

Based on GuruFocus' analysis, ClouDr Group stock appears to be undervalued. The current stock price of HK$0.51 is trading 37% below its estimated GF Value™ of HK$0.81. GuruFocus considers ClouDr Group to be Possible Value Trap.

Key valuation signals for HKSE:09955:

  • Beneish M-Score: -5.94
  • GF Value™: HK$0.81 vs. price of HK$0.51 (37% below fair value)
  • GF Score™: 43/100 with 9 warning signs

No single metric tells the full story. See the HKSE:09955 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ClouDr Group Business Description

Address No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. The company's in-hospital solution consists of sales of medical devices, consumables, and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies, and the out-of-hospital solution connects doctors and patients, and provides high-quality and trustworthy medical services through the AI vertical model ClouD GPT. The company generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.
43GF Score

Get the complete analysis for HKSE:09955

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.51
Price
HK$0.81
GF Value